Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India
Vishal Goyal(Chandigarh University), Fabiana Alves(Drugs for Neglected Diseases Initiative), Shambhu Nath Singh, Krishna Pandey(Rajendra Memorial Research Institute of Medical Sciences), Caryn Bern(University of California, San Francisco), Pradeep Das(Rajendra Memorial Research Institute of Medical Sciences), Vidya Nand Rabi Das(Rajendra Memorial Research Institute of Medical Sciences), Neena Verma(Rajendra Memorial Research Institute of Medical Sciences), Suman Rijal(Nepal Cancer Hospital and Research Center), Ravi Shankar Singh, Allen W. Hightower(Bangkok University), Jorge Alvar(Real Academia Española)
Cited by 37
Related Papers
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives
|Clinical Microbiology Reviews|2018|218
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
|PLoS neglected tropical diseases|2017|78
Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis
|BMC Public Health|2017|72